• Je něco špatně v tomto záznamu ?

Antimicrobial nanofibrous mats with controllable drug release produced from hydrophobized hyaluronan

L. Bardoňová, A. Kotzianová, K. Skuhrovcová, O. Židek, T. Bártová, J. Kulhánek, T. Hanová, K. Mamulová Kutláková, H. Vágnerová, V. Krpatová, M. Knor, J. Starigazdová, P. Holomková, R. Buffa, V. Velebný

. 2021 ; 267 (-) : 118225. [pub] 20210519

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003791

Due to their large active surface, high loading efficiency, and tunable dissolution profiles, nanofibrous mats are often cited as promising drug carriers or antimicrobial membranes. Hyaluronic acid has outstanding biocompatibility, but it is hydrophilic. Nanofibrous structures made from hyaluronan dissolve immediately, making them unsuitable for controlled drug release and longer applications. We aimed to prepare a hyaluronan-based antimicrobial nanofibrous material, which would retain its integrity in aqueous environments. Self-supporting nanofibrous mats containing octenidine dihydrochloride or triclosan were produced by electrospinning from hydrophobized hyaluronan modified with a symmetric lauric acid anhydride. The nanofibrous mats required no cross-linking to be stable in PBS for 7 days. The encapsulation efficiency of antiseptics was nearly 100%. Minimal release of octenidine was observed, while up to 30% of triclosan was gradually released in 72 h. The nanofibrous materials exhibited antimicrobial activity, the fibroblast viability was directly dependent on the antiseptic content and its release.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003791
003      
CZ-PrNML
005      
20250318144509.0
007      
ta
008      
220113e20210519xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.carbpol.2021.118225 $2 doi
035    __
$a (PubMed)34119178
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Bardoňová, Lenka $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic; Nanotechnology Centre, Energy and Environmental Technology Centre, VŠB - Technical University of Ostrava, 17. listopadu 2172/15, 708 00 Ostrava, Czech Republic. Electronic address: bardonova@contipro.com
245    10
$a Antimicrobial nanofibrous mats with controllable drug release produced from hydrophobized hyaluronan / $c L. Bardoňová, A. Kotzianová, K. Skuhrovcová, O. Židek, T. Bártová, J. Kulhánek, T. Hanová, K. Mamulová Kutláková, H. Vágnerová, V. Krpatová, M. Knor, J. Starigazdová, P. Holomková, R. Buffa, V. Velebný
520    9_
$a Due to their large active surface, high loading efficiency, and tunable dissolution profiles, nanofibrous mats are often cited as promising drug carriers or antimicrobial membranes. Hyaluronic acid has outstanding biocompatibility, but it is hydrophilic. Nanofibrous structures made from hyaluronan dissolve immediately, making them unsuitable for controlled drug release and longer applications. We aimed to prepare a hyaluronan-based antimicrobial nanofibrous material, which would retain its integrity in aqueous environments. Self-supporting nanofibrous mats containing octenidine dihydrochloride or triclosan were produced by electrospinning from hydrophobized hyaluronan modified with a symmetric lauric acid anhydride. The nanofibrous mats required no cross-linking to be stable in PBS for 7 days. The encapsulation efficiency of antiseptics was nearly 100%. Minimal release of octenidine was observed, while up to 30% of triclosan was gradually released in 72 h. The nanofibrous materials exhibited antimicrobial activity, the fibroblast viability was directly dependent on the antiseptic content and its release.
650    _2
$a buňky 3T3 $7 D016475
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $x chemie $x farmakologie $x toxicita $7 D000900
650    _2
$a léky s prodlouženým účinkem $x chemie $x farmakologie $x toxicita $7 D003692
650    _2
$a nosiče léků $x chemie $x farmakologie $x toxicita $7 D004337
650    _2
$a uvolňování léčiv $7 D065546
650    _2
$a kyselina hyaluronová $x chemie $x farmakologie $x toxicita $7 D006820
650    _2
$a hydrofobní a hydrofilní interakce $7 D057927
650    _2
$a iminy $x chemie $x farmakologie $x toxicita $7 D007097
650    _2
$a myši $7 D051379
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a nanovlákna $x chemie $x toxicita $7 D057139
650    _2
$a Pseudomonas aeruginosa $x účinky léků $7 D011550
650    _2
$a pyridiny $x chemie $x farmakologie $x toxicita $7 D011725
650    _2
$a Staphylococcus aureus $x účinky léků $7 D013211
650    _2
$a triclosan $x chemie $x farmakologie $x toxicita $7 D014260
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kotzianová, Adéla $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: kotzianova@contipro.com
700    1_
$a Skuhrovcová, Kristýna $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: skuhrovcova@contipro.com
700    1_
$a Židek, Ondřej $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: zidek@contipro.com
700    1_
$a Bártová, Tereza $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: bartova@contipro.com
700    1_
$a Kulhánek, Jaromír $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: kulhanek@contipro.com
700    1_
$a Hanová, Tereza $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: hanova@contipro.com
700    1_
$a Mamulová Kutláková, Kateřina $u Nanotechnology Centre, Energy and Environmental Technology Centre, VŠB - Technical University of Ostrava, 17. listopadu 2172/15, 708 00 Ostrava, Czech Republic. Electronic address: katerina.mamulova.kutlakova@vsb.cz
700    1_
$a Vágnerová, Hana $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: vagnerova@contipro.com
700    1_
$a Krpatová, Věra $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: krpatova@contipro.com
700    1_
$a Knor, Michal $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: michal.knor@seznam.cz
700    1_
$a Starigazdová, Jana $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: starigazdova@contipro.com
700    1_
$a Holomková, Pavlína $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: holomkova@contipro.com
700    1_
$a Buffa, Radovan $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: buffa@contipro.com $7 xx0330178
700    1_
$a Velebný, Vladimír $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: velebny@contipro.com
773    0_
$w MED00006149 $t Carbohydrate polymers $x 1879-1344 $g Roč. 267 (20210519), s. 118225
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34119178 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20250318144506 $b ABA008
999    __
$a ok $b bmc $g 1751296 $s 1154940
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 267 $c - $d 118225 $e 20210519 $i 1879-1344 $m Carbohydrate polymers $n Carbohydr Polym $x MED00006149
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...